Celldex Therapeutics Reports Q2 2026 Financial Results

What Happened
Celldex Therapeutics, Inc. (CLDX) announced its financial results for the second quarter of 2026 in a press release dated August 6, 2026. The company furnished that press release as Exhibit 99.1 to an SEC Form 8‑K (Item 2.02), which reports results of operations and financial condition for the quarter.

Key Details

• Filing date: August 6, 2026 (Form 8‑K filed to the SEC).
• Event: Announcement of second‑quarter 2026 financial results (press release furnished as Exhibit 99.1).
• Exhibits: Exhibit 99.1 (press release) and Inline XBRL cover page (Exhibit 104) are included in the filing.
• Item referenced: Item 2.02 — Results of Operations and Financial Condition (no executive changes, mergers, or bankruptcies reported in this filing).

Why It Matters
Quarterly results provide updated information on earnings, revenue, cash position and other financial metrics that can affect Celldex’s stock and investor outlook. Retail investors should review the furnished press release (Exhibit 99.1) for the specific revenue, profit/loss, and cash/runway figures and any commentary on guidance or pipeline progress. This 8‑K signals material financial disclosure; consider reading the press release and the company’s full SEC filings to evaluate the impact on your holdings.